Irreversible Loss of Fibromyalgia Students Lessons Learnt from Ongoing Counseling during Follow?Up Pharmacy Instituions in India

Author Details

Rahul Hajare

Journal Details

Published

Published: 16 February 2019 | Article Type :

Abstract

Fibromyalgia have one of the leading causes of neurological disorders and stroke in pharmaceutical Instituions. Health has the ability of a biological system convert into personal satisfaction. The world health organization (WHO) literature for human health in a broader sense in its 1948 constitution as “a state of complete physical and well-being and not merely the absence of disease or infirmity. It has been subject to controversy, in particular as poor transportation facility in pharmacy institution lacking operational value, the ambiguity in developing low health strategies and because of the problem created by use of the word “social determinants of health”, which makes it practically impossible to achieve healthy environments. Understanding student health and disease with private based co-educational pharmaceutical institution has not transportation facility and low quality food in suburban areas of developing cities in India cannot ignore. Early decompressive adrenal insufficiency has accepted in medical science due to health imbalance. Fibromyalgia especially from junior students to senior students living with private institution with poor quality of life and facility can translate into permanent disability in the world. We cannot compare Fibromyalgia with joint pain. Fibromyalgia cannot ignore because it has weaken immunity has unfortunately not measured in the above series.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © Author(s) retain the copyright of this article.

Statistics

235 Views

356 Downloads

Volume & Issue

Article Type

How to Cite

Citation:

Rahul Hajare. (2019-02-16). "Irreversible Loss of Fibromyalgia Students Lessons Learnt from Ongoing Counseling during Follow?Up Pharmacy Instituions in India." *Volume 2*, 1, 14-18